Company: BDRX
Filing Date: 2025-01-17
Form Type: F-1
Source: 0001214659-25-000922
Chunk: 232

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-17
Form: F-1
Chunk 232
---
 required to formally apply a recognized corporate governance code. While we are no longer traded
on AIM, we have chosen to adopt the principles of the Quoted Companies Alliance Corporate Governance Code for Small and Mid-Sized Quoted
Companies, or the QCA Code. The QCA Code identifies ten principles to be followed in order for companies to deliver growth in long term
shareholder value, encompassing and efficient, effective and dynamic management framework, accompanied by good communication, to promote
confidence and trust.

The Board of Directors is responsible for inter alia, approving interim and annual financial statements, formulating and monitoring our strategy, approving financial plans and reviewing
performance, as well as complying with legal, regulatory and corporate governance matters. There is a schedule of matters reserved for
the Board of Directors.

The Board of Directors meets
regularly to consider strategy, performance and the framework of internal controls. To enable the Board of Directors to discharge its
duties, all directors receive appropriate and timely information. Briefing papers are distributed to all directors in advance of board
meetings.

Board Committees

We have established audit,
nomination, and remuneration committees of the Board of Directors with formally delegated duties and responsibilities. From time to time,
separate committees may be set up by the Board of Directors to consider specific issues when the need arises.

Audit Committee

The Audit Committee consists
of three members: Dr. Turton (Chairman), Dr. Parker and Ms. Merchant. During 2023, Dr. de Vries served on the Audit Committee until the
appointment of Ms. Merchant on January 22, 2024. The Board of Directors has determined that Dr. Turton, Dr. Parker and Ms. Merchant are
independent under Rule 10A-3 of the Exchange Act and that Dr. Turton qualifies as an “audit committee financial expert” as
defined under in Item 16A of Form 20-F.

| 114 |

The Audit Committee of the
Board of Directors assists the Board of Directors in discharging its responsibilities with regard to financial reporting, external and
internal audits and controls, including reviewing and monitoring the integrity of the Company’s annual and interim financial statements,
advising on the appointment of external auditors, reviewing and monitoring the extent of the non-audit work undertaken by external auditors,
overseeing our relationship with our external auditors, reviewing the effectiveness of the external audit process and reviewing the effectiveness
of our internal control review function. The ultimate responsibility for